With its targeted multimodal approach, NeuroAiD™II offers a broad range of therapeutic benefits to TBI patients. NeuroAiD™II was well-tolerated by TBI patients with a favourable safety profile. SINGAPORE, Dec. 04, 2023 (GLOBE NEWSWIRE) — Moleac announced promising results from the SAMURAI double-blind study in patients with mild traumatic brain injury (mTBI) receiving a 6-month course […]

RICHMOND, Canada, Dec. 04, 2023 (GLOBE NEWSWIRE) — Today, General Fusion announced that Canada’s Strategic Innovation Fund (SIF) has awarded CA$5 million to support research and development to advance the company’s Magnetized Target Fusion (MTF) demonstration at its Richmond headquarters. Called LM26, this ground-breaking machine will progress major technical milestones required to commercialize zero-carbon fusion […]

Dubai, United Arab Emirates, Dec. 04, 2023 (GLOBE NEWSWIRE) — The UN Global Compact, together with the UN Environment Programme (UNEP), and UN Climate Change (UNFCCC), brought together senior executives of business, industry, finance, civil society, the United Nations and Government at the 11th High-Level Meeting of Caring for Climate at COP28. Those present discussed […]